摘要:
The present invention relates to steroid compounds of general formula X, which may advantageously be employed to stimulate meiosis in human oocytes, the steroid being specifically characterized by amino nitrogen bonded to C17 of the steroid skeleton via a spacer A.
摘要:
The invention relates to a new method comprising different ways of producing compounds of formula (1). The invention further relates to the hitherto unknown compounds of formulas (3), (4), (5), (6), (7), (8), (9), (10), (11), (12), (13), (14) and (15), also in the form of intermediate products.
摘要:
The present invention relates to thiomorpholino steroid compounds of general formula (I), which may advantageously be employed to stimulate meiosis in human oocytes, the steroid being specifically characterized by a thiomorpholino moiety bonded to C17 of the steroid skeleton via an alkylen spacer.
摘要:
The present invention relates to pharmaceutically active 14β-H-sterols, to pharmaceutical compositions comprising them and to the use of these novel compounds for the preparation of medicaments. More particularly it has been found that the 14β-H-sterols of the invention can be used for regulating meiosis.
摘要:
The invention relates to a new method comprising different ways of producing compounds of formula (1). The invention further relates to the hitherto unknown compounds of formulas (3), (4), (5), (6), (7), (8), (9), (10), (11), (12), (13), (14) and (15), also in the form of intermediate products.
摘要:
The invention relates to novel benzimidazole derivatives with general formula (I), whereby the radicals R?1, R2, R3¿, A, B, Y and Z have the meanings as cited in the description and in the claims. The invention also relates to the use of these compounds for producing a medicament used for the treatment and prophylaxis of diseases associated with a microglia-activation, and to pharmaceutical preparations containing these compounds.
摘要:
The invention relates to novel benzimidazole derivatives of general formula (I), wherein the groups R?1, R2, R3¿, A, B and Y are defined as per the definition and the claims. The invention also relates to the use of these compounds for producing a medicament for the prophylaxis and treatment of diseases linked to the activation of microglia and to pharmaceutical preparations containing said compounds.